Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 8/2016

01-08-2016 | Letter to the Editor

Immune thrombocytopenia purpura associated with multiple myeloma

Authors: Eamonn Faller, Lucy Chapman, Helen Enright, Paul Browne, Johnny McHugh, Ronan Desmond

Published in: Annals of Hematology | Issue 8/2016

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Verdirame JD, Feagler JR, Commers JR (1985) Multiple myeloma associated with immune thrombocytopenic purpura. Cancer 56:1199–1200CrossRefPubMed
2.
Gupta V, Hegde UM, Parameswaran R, Newland AC (2000) Multiple myeloma and immune thrombocytopenia. Clinical and Laboratory Haematology 22:239–242CrossRefPubMed
3.
Falco P, Bertola A, Bringhen S et al (2004) Successful management of immune thrombocytopenic purpura with thalidomide in a patient with multiple myeloma. The Hematology Journal 5:456–457CrossRefPubMed
4.
5.
Tabata R, Tabata C, Tazoh A, Nagai T (2012) Low dose cepharanthine ameliorates immune thrombocytopenic purpura associated with multiple myeloma. Int Immunopharmacol 13:242–244CrossRefPubMed
Metadata
Title
Immune thrombocytopenia purpura associated with multiple myeloma
Authors
Eamonn Faller
Lucy Chapman
Helen Enright
Paul Browne
Johnny McHugh
Ronan Desmond
Publication date
01-08-2016
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 8/2016
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-016-2694-y

Other articles of this Issue 8/2016

Annals of Hematology 8/2016 Go to the issue

Letter to the Editor

Abdominal aortic thrombosis secondary to reactive thrombocytosis in a patient with iron deficiency anemia

Letter to the Editor

A rare composite lymphoma: follicular and in situ mantle cell

Original Article

Bortezomib-based induction improves progression-free survival of myeloma patients harboring 17p deletion and/or t(4;14) and overcomes their adverse prognosis

Letter to the Editor

Multiple cytokine-producing primary cutaneous anaplastic large cell lymphoma

Original Article

Prediction of high risk for death in patients with follicular lymphoma receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in first-line chemotherapy

Letter to the Editor

Seriously overestimated prognostic value of baseline and interim FDG-PET in diffuse large B cell lymphoma
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits